Remove Cardiovascular Disease Remove Lipid disorders Remove Research
article thumbnail

Researcher finds increased risk of cardiovascular disease in people with hereditary lipid disorders

Medical Xpress - Cardiology

Tigist Wodaje from the Endocrinology Unit at the Department of Medicine, Huddinge (MedH), is defending her thesis, "Hereditary hypercholesterolemia and cardiovascular disease: functional and epidemiological aspects," on 14 December, 2023. The main supervisor is Jonas Brink (MedH).

article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable risk factors. As a leading cause of cardiovascular disease, dyslipidemia also has far-reaching implications for cognitive health, underscoring its broad impact.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. This approach improves patient outcomes and enhances the efficiency and satisfaction of healthcare providers across specialties.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

1 The most common adverse event leading to discontinuation was gastrointestinal disorders, occurring in 10% of patients in the Wegovy group and 2% in the placebo group. Between 1999 and 2020, obesity-related cardiovascular disease deaths tripled in the U.S., Centers for Disease Control and Prevention. mg and 36.4%

Obesity 111